Income Statement (TTM)
Med Paper S.A. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 63 | 58 | 63 | 69 | 74 | 79 | 95 | 110 | 123 | 135 | 130 | 126 | 117 | 108 | 106 |
| Change (%) | -6.71 | 8.62 | 7.93 | 7.65 | 7.10 | 19.88 | 16.58 | 11.02 | 9.92 | -3.30 | -3.42 | -7.14 | -7.69 | -2.13 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 38 | 35 | 37 | 38 | 43 | 47 | 55 | 64 | 72 | 80 | 76 | 71 | 64 | 54 | 57 |
| Change (%) | -9.00 | 5.40 | 5.12 | 10.76 | 9.72 | 18.20 | 15.40 | 12.89 | 11.42 | -5.53 | -5.85 | -10.02 | -15.67 | 4.66 | |
| % of Revenue | 60.85 | 59.35 | 57.59 | 56.09 | 57.72 | 59.13 | 58.30 | 57.70 | 58.68 | 59.48 | 58.11 | 56.65 | 54.89 | 50.15 | 53.63 |
| Gross Operating Profit | 25 | 24 | 27 | 30 | 31 | 32 | 39 | 47 | 51 | 55 | 55 | 55 | 53 | 54 | 49 |
| Change (%) | -3.14 | 13.32 | 11.75 | 3.67 | 3.54 | 22.31 | 18.24 | 8.46 | 7.80 | -0.04 | -0.04 | -3.38 | 2.02 | -8.96 | |
| % of Revenue | 39.15 | 40.65 | 42.41 | 43.91 | 42.28 | 40.87 | 41.70 | 42.30 | 41.32 | 40.52 | 41.89 | 43.35 | 45.11 | 49.85 | 46.37 |
| SG&A | 22 | 22 | 25 | 27 | 28 | 29 | 31 | 33 | 34 | 35 | 35 | 35 | 34 | 36 | 36 |
| Change (%) | 0.38 | 9.55 | 8.72 | 5.17 | 4.92 | 6.30 | 5.93 | 2.30 | 2.25 | 1.17 | 1.16 | -2.93 | 5.43 | 0.36 | |
| % of Revenue | 35.60 | 38.31 | 38.64 | 38.92 | 38.02 | 37.25 | 33.03 | 30.01 | 27.65 | 25.72 | 26.91 | 28.19 | 29.46 | 33.65 | 34.51 |
| R&D | |||||||||||||||
| Change (%) | |||||||||||||||
| % of Revenue | |||||||||||||||
| OpEx | 66 | 63 | 66 | 69 | 75 | 82 | 93 | 104 | 112 | 121 | 117 | 113 | 105 | 97 | 99 |
| Change (%) | -5.33 | 5.26 | 5.00 | 8.99 | 8.25 | 13.66 | 12.02 | 8.26 | 7.63 | -3.29 | -3.40 | -7.08 | -7.62 | 2.45 | |
| % of Revenue | 105.42 | 106.98 | 103.67 | 100.85 | 102.12 | 103.21 | 97.85 | 94.02 | 91.68 | 89.77 | 89.78 | 89.79 | 89.85 | 89.92 | 94.13 |
| Operating Income | -3 | -4 | -2 | -1 | -2 | -3 | 2 | 7 | 10 | 14 | 13 | 13 | 12 | 11 | 6 |
| Change (%) | 20.15 | -42.82 | -74.90 | 166.69 | 62.50 | -180.21 | 224.67 | 54.38 | 35.22 | -3.42 | -3.54 | -7.67 | -8.31 | -42.98 | |
| % of Revenue | -5.42 | -6.98 | -3.67 | -0.85 | -2.12 | -3.21 | 2.15 | 5.98 | 8.32 | 10.23 | 10.22 | 10.21 | 10.15 | 10.08 | 5.87 |
| Interest Expense | -4 | -4 | -3 | -3 | -2 | -1 | -2 | -3 | -4 | -5 | -5 | -5 | -5 | -5 | -3 |
| Change (%) | -6.46 | -12.74 | -14.60 | -23.37 | -30.50 | 47.57 | 32.23 | 39.86 | 28.50 | -0.36 | -0.36 | -3.40 | -3.52 | -29.58 | |
| % of Revenue | -6.20 | -6.22 | -5.00 | -3.95 | -2.81 | -1.83 | -2.25 | -2.55 | -3.21 | -3.76 | -3.87 | -3.99 | -4.15 | -4.34 | -3.12 |
| Net Income | -8 | -9 | -6 | -4 | 3 | 9 | 13 | 17 | 12 | 7 | 7 | 7 | 6 | 6 | 8 |
| Change (%) | 10.94 | -24.53 | -32.50 | -158.73 | 270.28 | 40.56 | 28.86 | -28.38 | -39.62 | -5.75 | -6.10 | -6.27 | -6.68 | 38.85 | |
| % of Revenue | -12.32 | -14.65 | -10.18 | -6.37 | 3.47 | 12.01 | 14.08 | 15.56 | 10.04 | 5.51 | 5.37 | 5.23 | 5.27 | 5.33 | 7.56 |
Source: Capital IQ
